CGAS and metabolic dysfunction-associated steatohepatitis: Aberrant cGAS/STING activation might also play a role in diseases such as nonalcoholic steatohepatitis (NASH) and chronic obstructive pulmonary disease (COPD); nevertheless, this still requires further evaluation.